Bone Biologics Corp
BBLG
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.79M
Close$
$2.19
131.9% upside
Current Fair Value
131.9% upsideUndervalued by 131.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.79 Million |
|---|---|
| Enterprise Value | $-2,743,649.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.65 |
| Beta | 0.53 |
| Outstanding Shares | 1,795,260 |
Return
| Return on Equity | -61.20% |
|---|---|
| Return on Assets | -57.40% |
| Return on Invested Capital | -62.03% |
Valuation & Multiples
| P/E Ratio | -0.31 |
|---|---|
| PEG | 1.24 |
| Price to Sales | - |
| Price to Book Ratio | 0.47 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.95 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.54
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.25%▼ 4.10% |
|---|---|
| Total Invested | $4,854▼ 93.45% |
| Investors Holding | 3▼ 4.00% |
ESG Score
No data
About Bone Biologics Corp
2 employees